Product: Zonisamide Capsules, USP, 50 mg, packaged in 100-count bottles, Rx only, Manufactured by: Glenmark Pharmaceuticals, Inc., USA Monroe, NC 28110, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-129-01
Reason for recall: cGMP deviations
Recall initiated: 20220425
Status: Completed
Classification: Class II
Recall type: Voluntary: Firm initiated